Khandwala Sec. (KHANDSE)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹17.7 |
| Market Cap | ₹27 Cr |
| P/E Ratio | 0 |
| ROCE | -14.51% |
| ROE | -9.3% |
| Dividend Yield | 0% |
| Profit Growth | -190.74% |
| Debt/Equity | 0.1 |
| Sales Growth | 99.6% |
| Promoter Holding | 48.3% |
| 52-Week Range | ₹12.2 — ₹26.88 |
| Sector | Capital Markets |
| Book Value | ₹18.28 |
Strengths
- Trades at P/B 0.81, a 19% discount to book value of ₹20.58.
- Low leverage with debt/equity 0.10 limits financial distress risk.
- Promoter holding 48.30% aligns ownership with minority investors.
- Latest quarter's net loss is negligible, near breakeven, on sales of ₹1 Cr.
Concerns
- ROE -9.30% and ROCE -14.51% indicate capital destruction, not compounding.
- Sales growth -60.74% and profit growth -190.74% show collapsing business momentum.
- Piotroski F-Score 2/9 suggests weak operating efficiency, leverage, or asset quality.
- Zero dividend yield and no earnings make valuation dependent on uncertain recovery.
AI Analysis
I start with a business I can understand. Khandwala is a stockbroker, and brokers face intense competition and volatile volumes. There is no obvious durable moat here. The first thing I see is a stock selling at ₹16.75 against book value of ₹20.58—a P/B of 0.81. That makes it look like an asset play. But Graham taught me that a rupee of book value is only worth a rupee if management can earn a decent return on it. Khandwala cannot. Return on equity is -9.30%, and return on capital employed is -14.51%. Sales are down 60.74% from a year earlier, and profit growth is -190.74%. P/E is meaningless at 0.00 because there are no positive earnings. The Piotroski F-Score of 2 out of 9 reinforces the picture of financial weakness. On the positive side, debt is only 0.10 times equity, so the balance sheet is not stretched, and promoters own 48.30%, which is better than a management that ignores shareholders. Still, no dividend is being paid, so a shareholder must rely entirely on a recovery that is not visible. The latest quarter shows sales of just ₹1 crore and a loss of about ₹0 crore; that is better than a big loss, but it is not a turnaround. At a market cap of ₹26 crore, this is a small company, and small brokers have little pricing power. I would treat this as a potential asset play only if book value stabilises and earnings turn positive. Until then, buying purely for the 19% discount to book is catching a falling knife. I prefer a wonderful business at a fair price, and this is not one.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer